Catherine Kielar is Head of Access & Pricing Strategy at Genesis Research Group, bringing global healthcare and life sciences experience to the development of market access and pricing strategies. Her background includes leadership in global market access, evidence generation, and strategic consulting, including previous experience with Avalere Health. Catherine combines scientific and strategic expertise to help organizations address complex access, pricing, and evidence challenges across the product lifecycle.
